A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Status: | Completed |
---|---|
Conditions: | Diabetes |
Therapuetic Areas: | Endocrinology |
Healthy: | No |
Age Range: | 18 - 70 |
Updated: | 2/11/2017 |
Start Date: | August 2012 |
End Date: | May 2013 |
Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study to Evaluate the Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin
The purpose of this study is to compare the safety and effect of TTP054 versus placebo on
glucose control in patients with type 2 diabetes.
glucose control in patients with type 2 diabetes.
Inclusion Criteria:
- Diagnosis of type 2 diabetes mellitus
- On a stable (for the last 3 months) regimen of either metformin alone or metformin in
combination with one additional acceptable oral antidiabetic (OAD) agent
- HbA1c: Metformin only: 7.0 - 11.0%; Metformin + acceptable OAD agent: 6.5 - 9.5%
Exclusion Criteria:
- History or evidence of significant diabetic complications
- History of heart attack, stroke or congestive heart failure
- Severe, uncontrolled hypertension
- Frequent hypoglycemia
- Women of child-bearing potential
We found this trial at
18
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials